How Do Regulatory Barriers Affect Clinical Trials?
Regulatory requirements for clinical trials can be stringent, often involving extensive documentation, ethical reviews, and approvals from multiple regulatory bodies. These requirements can slow down the initiation and progression of clinical trials, making it difficult for researchers to test new cancer therapies. Additionally, patient recruitment for trials can be hampered by these barriers, affecting the overall success of the research.
